2023 JCSA Prohibited Sunstances & Medication Rules

PROHIBITED

SUBSTANCES

AND MEDICATION RULES

All horses will be subject to testing for “prohibited substances” in accordance with the requirements set out in Article 6 of the International Agreement of the International Federation of Horseracing Authorities (IFHA), and as bound by the Racing Rules of the JCSA. Horses are tested for the presence of “prohibited substances” through the routine collection of both pre-and post race blood and urine samples.

A prohibited substance is considered to be any substance that is capable of acting directly or indirectly on any of the mammalian body systems, consistent with the model definition in Article 6 of the IFHA International Agreement

Prohibited substances include but are not limited to substances (including their metabolites, isomers, isomers of metabolites and pro drugs) which fall into any of the categories specified in JCSA rules (Article 119).

The JCSA Officials reserve the right to carry out random inspections of trainer’s tack boxes / trunks / equipment both in International and local quarantine stables.

The JCSA gives notice that the following are prohibited substances:

(1) Substances capable at any time of causing either directly or indirectly an action or effect, or both an action and effect, within one or more of the following mammalian body systems: (a)the nervous system (b)the cardiovascular system (c)the respiratory system (d)the digestive system (e)the urinary system (f) the reproductive system (g)the musculoskeletal system (h)the blood system (i) the immune system, except for licensed vaccines (j) the endocrine system (k)endocrine secretions and their synthetic counterparts

(2) Substances falling within, but not limited to, the following categories: acidifying agents adrenergic blocking agents adrenergic stimulants agents affecting calcium and bone metabolism alcohols alkalinising agents anabolic agents anaesthetic agents analgesics antiangina agents antianxiety agents antiarrhythmic agents anticholinergic agents anticoagulants anticonvulsants antidepressants antiemetics antifibrinolytic agents antihistamines antihypertensive agents anti inflammatory agents antinauseants antineoplastic agents antipsychotic agents antipyretics antirheumatoid agents antispasmodic agents antithrombotic agents antitussive agents bloodcoagulants bronchodilators bronchspasm relaxants buffering agents central nervous system stimulants cholinergic agents corticosteroids depressants diuretics erectile dysfunction agents fibrinolytic agents haematopoietic agents haemostatic agents hormones (including trophic hormones) and their synthetic counterparts hypnotics hypoglycaemic agents hypolipidaemic agents immunomodifiers masking agents

RULES

muscle relaxants narcotic analgesics neuromuscular agents plasma volume expanders respiratory stimulants sedatives stimulants sympathomimetic amines tranquillisers vasodilators vasopressor agents vitamins administered by injection oxygen carriers agents that directly or indirectly affect or manipulate gene expression

(3) Also metabolites, isomers, isomers of metabolites and pro-drugs of substances mentioned above are considered prohibited substances

Threshold levels

The JCSA gives notice that the following substances are also deemed to be prohibited substances when present above these thresholds:

• Prednisolone 0.01 microgram free prednisolone per millilitre in urine

• Total carbon dioxide 37mmol/L in plasma. See section on TC02 testing and alkalinising agents below

• Arsenic 0.3 microgram total arsenic per millilitre in urine

• Total cobalt at a mass concentration of 0.1 micrograms per millilitre in urine or 0.025 microgram total cobalt (free and protein bound) per millilitre in plasma

• Boldenone – 0.015 micrograms free and conjugated boldenone per millilitre in urine from male horses (other than geldings)

• Dimethyl sulphoxide 15 micrograms per millilitre in urine or 1 microgram per millilitre in plasma

• In male horses other than geldings, 0.045 microgram free and glucuroconjugated 5α estrane 3β, 17α diol per millilitre in urine when, at the screening stage, the free and glucuroconjugated 5α-estrane-3β, 17α-diol exceeds the free and glucuroconjugated 5(10)estrene 3β, 17α diol in urine

• Hydrocortisone 1 microgram hydrocortisone per millilitre in urine

• Methoxytyramine 4 micrograms free and conjugated 3 methoxytyramine per millilitre in urine

• Salicylic acid 750 micrograms salicylic acid per millilitre in urine or 6.5 micrograms per millilitre in plasma

• Testosterone – 0.02 microgram free and conjugated testosterone per millilitre in urine from geldings, or 100 picograms free testosterone per millilitre in plasma from geldings, fillies and mares (unless in foal), or 0.055 microgram free and conjugated testosterone per millilitre in urine from fillies and mares (unless in foal)

Only levels above the thresholds shall be taken as positive.

RULES

The following classifications of prohibited substances also apply:

Substances prohibited at all times:

Substances that have no legitimate justification for use in racehorses at any time under a zerotolerance policy. They include but are not limited to:

• Non approved substances any substance not addressed by any of the subsequent classes of substances, and which has no current approval by any government regulatory authority for veterinary use, or any substance not universally recognised by veterinary regulatory authorities as valid veterinary therapeutic treatment.

• Anabolic agents:

(a) anabolic androgenic steroids

(b) other anabolic agents, including but not limited to selective androgen receptor modulators (SARMs)

(c) beta-2 agonists, unless the substance is prescribed by a veterinarian as a bronchodilator at the appropriate dose

• Peptide hormones, growth factors and related substances:

(a) erythropoiesis-stimulating agents, including but not limited to erythropoietin (EPO), epoetin alfa, epoetin beta, darbepoetin alfa, and methoxypolyethylene glycol epoetin beta, peginesatide, hypoxia inducible factor (HIF) stabilisers and HIF activators

(b) growth hormones and growth hormone releasing factors, insulin like growth factor 1 (IGF 1), and other growth factors

(c) synthetic proteins and peptides and synthetic analogues of endogenous proteins and peptides not registered for medical or veterinary use

• Hormones and metabolic modulators:

(a) aromatase inhibitors

(b) selective estrogen receptor modulators (SERMs) and other anti estrogenic substances (c) agents modifying myostatin function, including but not limited to myostatin inhibitors

(d) insulins

(e) peroxisome proliferator activated receptor δ (PPARδ) agonists, including but not limited to GW 1516

(f) AMPK activators, including but not limited to AICAR (5 aminoimidazole 4 carboxamide 1 β D ribofuranoside)

(g) other agents that directly or indirectly affect or manipulate gene expression.

• Allosteric effectors of haemoglobin, including but not limited to ITPP (myo inositol trispyrophosphate)

• Venoms of any species or derivatives thereof

• Oxygen carriers

• Any other substances with a similar chemical structure or similar biological effect(s) to the substances listed above.

RULES

Substances with a legitimate therapeutic use:

This category includes substances that are “prohibited substances” but which are not included in the list of substances which are prohibited at all times. They are permitted for use on a horse in training but cannot be detected in a race day sample. These substances include antiinflammatory agents licensed for use in horses, and other medications used in the legitimate management of conditions during training.

Relevant international screening limits (ISL’s) for therapeutic substances in urine and plasma will apply during the screening of samples from horses competing under the rules of JCSA.

(See: https://www.ifhaonline.org/default.asp?section=IABRW&area=1 and https://www.ifhaonline.org/default.asp?section=IABRW&area=6 )

The JCSA also accepts the IFHA residue limits for the control of Feed Contaminants and Environmental Substances as set out at: https://www.ifhaonline.org/default.asp?section=IABRW&area=18

TCO2 testing and alkalinising agents

The JCSA has stringent procedures for the testing of total carbon dioxide (TCO2) in blood samples. There are clear restrictions on the pre race administration of alkalinising agents which are highlighted in the Notices section of the JCSA Rules and set out below.

The following TCO2 testing procedures will apply for horses competing under the rules of JCSA:

• Horses will be tested for TCO2 pre-race.

• Horses will be sampled 45 50 minutes before race time blood is taken and where analysis shows that a horse has a level of between 36 mmol/L and 37 mmol/L, a second test is taken 10 minutes later.

• If the second test is equal to or above 37 mmol/L the horse is scratched. A third test is taken 30 minutes later and if the TCO2 level is below the permitted level, no penalty is imposed on the trainer.

• A horse sent for a third test will also be sent for blood and/or urine sampling which will be taken in the normal manner to that which is already done on a race day under a secure chain of custody and this sample will be sent for further testing for prohibited substances.

JCSA Rules Notice

ALKALINISING AGENTS

1. A person must not administer an alkalinising agent, in any manner, to a horse which is engaged to run in any race.

2. Any person who: a) administers an alkalinising agent; b) attempts to administer an alkalinising agent; c) causes an alkalinising agent to be administered; and/or d) is a party to the administration of, or an attempt to administer, an alkalinising agent, contrary to Article 119 commits an offence and may be penalised.

3. Where the Stewards are satisfied that a horse has, or is likely to have been, administered any alkalinising agent contrary to Article 119, the Stewards may prevent the horse from starting in any relevant race.

4. Where a horse has been administered any alkalinising agent contrary to Article 119, the horse may be disqualified from any relevant race in which the horse competed.

5. For the purposes of Article 119, ‘alkalinising agent’:

a) means any substance that may elevate the plasma total carbon dioxide (TCO2) of a horse when administered by any route;

b) includes but is not limited to substances that are bicarbonates, citrates, succinates, acetates, propionates, maleates, lactates and trometamol (THAM, Tris Buffer or Trometamine) and also include products marketed as urinary alkalinisers and hind gut buffers;

c) does not include substances that are alkalinising agents which are contained in commercial feeds and/or balanced commercial electrolyte supplements which when fed and consumed according to the manufacturers’ recommendations for normal daily use have a negligible effect on plasma TCO2.

Specific requirements regarding bisphosphonates

The following Notice appears in the JCSA Rules: Any bisphosphonate is not to be administered to a racehorse:

• under the age of three years and six months as determined by its recorded date of birth; and

• on the day of the race or on any of the 30 days before the day of the race in which the horse is declared to run.

The bisphosphonate product administered must be licensed for use in horses in the country in which it is being used and be administered in accordance with the label instructions. There must be a diagnosis determined by a veterinary surgeon that supports the use of a bisphosphonate as an appropriate treatment, and such treatment must be administered by a veterinary surgeon. Horsemen are reminded of the prolonged and unpredictable detection period of bisphosphonates following their administration.

Other restrictions

• Nebulisers are not allowed on race day.

• Horses must not have been administered extracorporeal shockwave therapy on the day of the race or on any five days before the day of the race in which the horse is declared to run.

• No medication will be permitted on race day.

• Throat flushes, no matter how innocuous their ingredients, are not accepted.

• The application of ice or chilled water to, or the use of whirlpool boots or similar systems on musculoskeletal structures are only permitted in the trainers’ stables on the morning of the race day, but are not permitted once the horse arrives in the race day stalls on the racecourse prior to the horse running in a race.

For further information on prohibited substances, treatment and medication, please contact JCSA veterinary officer:

Dr

Waleed Al Sanab

Email: walsanab@jcsa.sa

PENALTIES

6. Any person shall be liable to penalty if:

(a) they administer or cause to be administered any prohibited substance to a horse for the purpose of affecting its performance in a race, or any test.

(b) they administer or cause to be administered any prohibited substance which is detected in any sample from any horse prior to or following any race, or test.

7. Any trainer or other person in charge of a horse, which is presented to race or perform a test, or has raced or performed a test which is found (upon analysis) to have had administered to it a prohibited substance, shall be liable to a penalty.

8. The stewards may direct that samples taken from a horse pursuant be stored, in whole or in part and shall be disposed of only as directed.

9. Notwithstanding any other provision of the rules, the stewards may direct that a stored sample, in whole or in part, be submitted or resubmitted for any test to determine whether any prohibited substance was at the relevant time present in the system of the horse from which the sample was taken.

10. A person shall not attempt to stomach tube (nasogastric tube), a horse nominated for a race or within one (1) clear day of the commencement of the race. No nasogastric tube is allowed to be brought into the racecourse stables on the day of the race.

11. A person shall not attempt to use, or use an atomiser (nebuliser), face mask or other device for the administration of a prohibited substance to a horse nominated for a race within one (1) clear day of the commencement of the race.

12. The use of physical treatments such as acupuncture, ultrasound therapy, laser therapies and hyperbaric oxygen therapies are prohibited within one (1) clear day of the commencement of the race.

13. No person shall administer or cause to be administered any medication to a horse on race day prior to such horse running in a race.

14. The stewards may order the withdrawal from a race any horse that has received any medication in contravention of these rules.

15. Where it is established subsequent to a horse competing in a race, that the horse had received medication, it may be disqualified from the race.

For the purpose of these rules, medication means any treatment with drugs, prohibited substances or other substances.

RULES

SAMPLES

1. Samples taken from horses in pursuance of the powers conferred on the stewards shall be analysed by an accredited racing laboratory approved by the JCSA.

2. Upon the detection by an accredited racing laboratory of a prohibited substance in a sample from a horse, such laboratory shall notify its finding to the stewards, who shall then notify the trainer of the horse of such finding and give them the option to have the reserve portion of the sample tested at another JCSA-approved accredited racing laboratory. The trainer will have three days to notify the stewards of such requirement. A refusal by the trainer to test the reserve portion of the sample shall not prevent the stewards from having the reserve portion of the sample tested.

3. In the event of the other accredited racing laboratory detecting the same prohibited substance in the reserve portion of the sample, the certified findings of both accredited racing laboratories shall be conclusive evidence that a prohibited substance has been administered to the horse from which the sample was taken.

4. In the event that a confirmatory analysis is not requested, the findings of the accredited racing laboratory shall be conclusive evidence that a prohibited substance had been administered to the horse from which the sample was taken.

5. Notwithstanding anything contained in (1), (2), (3) and (4), the stewards may where samples are to be analysed for the plasma total carbon dioxide concentration (TCO₂) of a horse, send two samples for immediate analysis to an accredited racing laboratory.

DETECTION TIMES

The published detection times are not the period of time that the medication should be withheld. “Detection Time” is a piece of information released by racing authorities to stakeholders to assist professionals (veterinarians) to recommend a withdrawal time for a given horse. This allows the veterinarians to apply good veterinary practice in the use of therapeutic substances to treat racehorses. The overall process provides a fair and effective approach for controlling substances commonly used for treating racehorses and allows the eight member nations of the EHSLC to harmonise on the control of these substances through agreed limits of the sensitivity of screening procedures for raceday samples.

PLEASE NOTE THAT THE DETECTION TIMES SHOULD NOT BE CONFUSED WITH WITHDRAWAL TIMES

NB An adequate safety margin should be added to the detection time. Trainers must liaise with their treating veterinarians at home and if necessary, with the JCSA official veterinarians to avoid any medication rule violations

https://www.ehslc.com/images/uploads/documents/EHSLC_DETECTION_TIMES_(updated_1_ February_2021).pdf

PROHIBITED SUBSTANCES AND MEDICATION RULES

SUBSTANCE PREPARATION DOSE

ROUTE OF ADMNISTRATION (No. OF HORSES) DETECTION TIME (HOURS)

Acepromazine Sedalin® Vetoquinol UK Ltd 0.15mg/kg, single dose Oral (6) 72

Altrenogest

Butorphanol

Butyl Scopolamine/ Dipyrone (Metamizole)

Regumate® Equine MSD Animal Health 44ug/kg for 10 days, once daily Oral (4) 288*

Torbugesic® Fort Dodge Animal Health Ltd 100μg/kg, single dose i.v. (6) 72

Buscopan™ Compositum Boehringer Ingelheim

0.2mg/kg butyl scopolamine/ 25mg/kg dipyrone (Metamizole), single dose i.v. (6) 72

Butyl scopolamine Buscopan® Boehringer Ingelheim 0.3mg/kg, single dose i.v. (6) ≤48^

Carprofen Rimadyl® Pfizer Ltd 0.7mg/kg, single dose i.v. (6) 264

Cetirizine

Allacan® (Bristol Laboratories Ltd) 190mg twice daily for 4.5 days (9 doses) Oral (2) 96

Ciclesonide

Aservo® Equihaler® Ciclesonide inhalation solution 5.5mg/day/5days then 4.1mg/day/5days

Clenbuterol

Inhalation (6) 120

Ventipulmin™ Syrup (25 micrograms/ml) Boehringer Ingelheim 1.6µg/kg/day for 10 Days, once daily Oral (6) 312

Jockey Club of Saudi Arabia

PROHIBITED SUBSTANCES AND MEDICATION RULES

SUBSTANCE PREPARATION DOSE

Clenbuterol

Ventipulmin™ Injection (30 micrograms/ml) Boehringer Ingelheim

Clodronate

ROUTE OF ADMNISTRATION (No. OF HORSES) DETECTION TIME (HOURS)

0.3µg/kg/day for 5 Days, once daily Nebulised** (6) 144

Osphos® Dechra Veterinary Products 1.53mg/kg Single injection i.m. 30 days

Dantrolene Dantrium® 500mg for 3 days, once daily Oral (12) ≤48^

Dembrexine Sputolysin® Boehringer Ingelheim 0.3mg/kg, 9 doses at 12h intervals Oral (6) 96

Detomidine Domosedan® Orion Pharma, Finland 0.02mg/kg, single dose i.v. (10) 48^

Detomidine/ Butorphanol

Domosedan® Janssen Torbugesic® Pfizer

Dexamethasone isonicotinate

Dexamethasone sodium phosphate

10µg/kg followed after 5 minutes with 25µg/kg Torbugesic®, single dose i.v. (6) 72

Voren® Boehringer Ingelheim Ltd 0.03mg/kg, single dose (15ml/500kg horse) i.m (6) 336

Dexadreson® Intervet UK Ltd 0.06mg/kg, single dose (15ml/500kg horse) i.v. (6) 120

Jockey Club of Saudi Arabia

PROHIBITED SUBSTANCES AND MEDICATION RULES

SUBSTANCE PREPARATION DOSE

Dipyrone

Eltenac

Vetalgin® Intervet Deutschland GmbH

Telzenac® Schering Plough Animal Health

Firocoxib

Flunixin

Furosemide

Hydroxyzine

Ipratropium

Ketoprofen

Lidocaine

ROUTE OF ADMNISTRATION (No. OF HORSES) DETECTION TIME (HOURS)

30mg/kg, single dose i.v.(10) 72

0.5mg/kg for 5 days, once Daily i.v.(6) 192

Equioxx® Merial 100µg/kg for 7 days, once daily Oral (20) 360 (15 days)

Finadyne® Schering Plough 1mg/kg, single dose i.v. (4) 144

Dimazon™ Intervet 1mg/kg, single dose i.v. (6) 48^

Atarax® (Alliance Pharmaceuticals Ltd) 500mg twice daily for 4.5 days (9 doses) Oral (6) 96

Atrovent™ solution for nebulisation (0.5 mg /ml) Boehringer Ingelheim

Ketofen® Merial Animal Health Ltd

5.5µg/kg/day for 3 Days, once daily (16.5µg/kg in total)

Nebulised** (6) [MDI-Spacer] 120 [168]

2.2mg/kg for 5 days, once daily i.v.(6) 96

Norocaine® Norbrook Laboratories

300mg/15mL, single dose 60mg/3mL, single dose s/c (6) s/c (6) 72

Jockey Club of Saudi Arabia

PROHIBITED SUBSTANCES AND MEDICATION RULES

SUBSTANCE PREPARATION DOSE

Meclofenamic acid

Meclofenamic acid

ROUTE OF ADMNISTRATION (No. OF HORSES) DETECTION TIME (HOURS)

Not commercially available. Sigma (†see footnote) 2.2mg/kg/single Dose i.v. (6) 48^

Dynoton Biove Laboratory Arques, France 4mg/kg for 5 days, once daily Oral (6) 120

Meloxicam Metacam® Boehringer Ingelheim 0.6mg/kg for 14 days, once daily Oral (8) 72

Mepivacaine

Intra-Epicaine® Arnolds Vet Products Ltd 2mL/40mg, single dose (0.07 0.09mg/kg) s/c to lateral aspect of distal limb (6) 72

Mepivacaine Intra-Epicaine® Arnolds Vet Products Ltd 8mL/160mg, single dose (0.28 –0.36mg/kg) s/c neck (6) 72

Misoprostol Cytotec® 5µg/kg for 14 days, twice daily Oral (6) 48^

Naproxen Naprosyn™ Roche 10mg/kg for 5 days, once daily Oral (6) >360 (15 days)

Omeprazole

Gastrogard® 37% oral Paste Merial 1mg/kg for 28 days, once daily Oral (*see note) 48^

Jockey Club of Saudi Arabia

PROHIBITED SUBSTANCES AND MEDICATION RULES

SUBSTANCE PREPARATION DOSE

Equipazolone® Arnolds Vet Products Ltd

Phenylbutazone

Phenylarthrite™

Vetoquinol SA

Equipazolone® Intervet SA

Prednisolone

Procaine benzylpenicillin

Romifidine

Romifidine/ Butorphanol

Salbutamol

Tildronate

4.7mg/kg for 5 days, twice daily 8.8mg/kg, single dose 8.8mg/kg for 1 day, twice daily followed by; 4.4mg/kg for 10 days, twice daily

ROUTE OF ADMNISTRATION (No. OF HORSES) DETECTION TIME (HOURS)

Oral (2) i.v.(6)

Oral (6) 168

Prednidale® 25mg Dechra 1mg/kg, single dose Oral (6) 48^

Depocillin® MSD Animal Health 12mg/kg for 5 days, once or twice daily i.m. (4) 240

Sedivet® Boehringer Ingelheim 80µg/kg, single dose i.v. (8) 60

Sedivet®Boehringer Ingelheim Torbugesic® Pfizer

Ventolin Evohaler® Allen & Hansburys

60µg/kg followed after 5 minutes with 25µg/kg Torbugesic®, single dose i.v. (6) 72

5×100µg actuations per dose for 2 days at 4 hourly dosing during day

Inhaled via a pMDI through a spacer into nostrils (6) 72

Tildren® Ceva Animal Helath 0.1mg/kg/10 days i.v. (6) 30 days

Vedaprofen Quadrisol® Intervet SA 2mg/kg, single dose i.v. (6) 96

Jockey Club of Saudi Arabia

PROHIBITED SUBSTANCES AND MEDICATION RULES

SUBSTANCE PREPARATION DOSE

Xylazine Chanazine® Chanelle Animal Health

ROUTE OF ADMNISTRATION (No. OF HORSES) DETECTION TIME (HOURS)

0.4mg/kg, single dose i.v. (6) 72

† Prepared according to Johansson et al Pharmaceutical & Biomedical Analysis (1986) 4, 2 171 179.

* Calculated from several studies involving differing numbers of horses.

** This 5 day advice relates to true nebulisation.

^ The JCSA requires that a prohibited substance may not be given on the day of a race. No detection times less than 48 hours will be advised by the JCSA.

It is recommended that the trainers take all precautions through consultation and coordination with their treating veterinarian and the JCSA official veterinarians as required to avoid violations.

The classification of prohibited substances and therapeutic substances is subject to periodic review and amendments. Violations and penalties will be determined by the JCSA Rules of Racing and classification of prohibited substances. The ARCI (Association of Racing Commissioners International) list of prohibited substances will act as a guide and will remain non-binding.

The Medication, Testing and Safety rules outlined here should be followed and implemented by all trainers as a part of the JCSA Rules of Racing.

Jockey Club of Saudi Arabia